Primecap Management
CELL

Primecap Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Primecap Management’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-26,145
Closed -$186K – 344
2022
Q1 		$186K Hold
26,145
– – ﹤0.01% 338
2021
Q4 		$475K Buy
26,145
+1,487
+6% +$32.1K ﹤0.01% 339
2021
Q3 		$482K Buy
24,658
+3,000
+14% +$114K ﹤0.01% 336
2021
Q2 		$970K Hold
21,658
– – ﹤0.01% 329
2021
Q1 		$1.09M Buy
+21,658
New +$1.48M ﹤0.01% 322

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management's CELL Position: Q2 2022 in Review

Primecap Management sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2022, closing a stake of 26,145 shares — an estimated $186K sold.

Primecap Management first reported a position in CELL in Q1 2021 and held it in 5 quarters. The position peaked at $1.09M in Q1 2021. 123 funds tracked by Wall St. Rank hold CELL as of Q2 2022.

  • Primecap Management reported no remaining PhenomeX Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Primecap Management sold 26,145 PhenomeX Inc. Common Stock shares in Q2 2022, an estimated $186K.
  • Primecap Management first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • Primecap Management's PhenomeX Inc. Common Stock position peaked at $1.09M in Q1 2021.
  • 123 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2022.

Based on Primecap Management's 13F filing for Q2 2022, filed 11 Aug 2022.